Edition:
United States

Reata Pharmaceuticals Inc (RETA.OQ)

RETA.OQ on NASDAQ Stock Exchange Global Market

87.56USD
21 Sep 2018
Change (% chg)

$-4.19 (-4.57%)
Prev Close
$91.75
Open
$91.74
Day's High
$91.74
Day's Low
$84.04
Volume
525,191
Avg. Vol
112,497
52-wk High
$93.93
52-wk Low
$19.32

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

J. Warren Huff

64 2015 Chairman of the Board, President, Chief Executive Officer

Jason Wilson

48 2015 Chief Financial Officer and Vice President, Strategy

Dawn Bir

47 2017 Vice President, Chief Commercial Officer

Colin Meyer

39 Chief Medical Officer and Vice President, Product Development

Keith Ward

48 Vice President, Chief Development Officer